KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹8.81 Cr | ₹-0.72 Cr | ₹7.03 Cr | ₹1.61 Cr | ₹0.85 Cr |
What is the latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹8.81 Cr |
Mar2023 | ₹-0.72 Cr |
Mar2022 | ₹7.03 Cr |
Mar2021 | ₹1.61 Cr |
Mar2020 | ₹0.85 Cr |
How is Cash Flow from Financing Activities of KILITCH DRUGS (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹8.81 Cr | Positive | |
Mar2023 | ₹-0.72 Cr | Negative | |
Mar2022 | ₹7.03 Cr | 335.44 | |
Mar2021 | ₹1.61 Cr | 89.88 | |
Mar2020 | ₹0.85 Cr | - |
Compare Cash Flow from Financing Activities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹571.5 Cr | 1.1% | 1.2% | -2.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 1.1% |
1.2% |
-2.3% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses